Chimerix Stock Discussion

$Chimerix(CMRX.US)$ ONC206 is a second generation ClpP agonist and DRD2 antagonist that has demonstrated monotherapy anti-cancer activity in pre-clinical models in primary CNS tumors and solid tumors outside of the CNS.
Phase I dose escalation trials continue at the National Institutes of Health (NIH) and the Pacific Pediatric Neuro-Oncology Consortium (PNOC) in adult and pediatric CNS tumor patients, respectively. The dose escalation trials are currently dosing at a...

$Chimerix(CMRX.US)$ Strong Buy Rating for Chimerix on Robust Financials and Promising Drug Pipeline

$Chimerix(CMRX.US)$
This is all I need to hold and/or buy more on dips
"..Turning to clinical outcomes. The survival of H3 K27-mutant glioma patients who received ONC201 in the frontline setting following radiotherapy, which I'll notice the same setting of the ACTION trial was reported as 21.7 months from diagnosis in contrast to 12 months for patients who did not receive ONC201. Favorable survival outcomes among ONC201 treated patients were consistently observed across a variety of sensitivity ...

$Chimerix(CMRX.US)$  go to bngo stock

$Chimerix(CMRX.US)$ Hello!!

QUICK SCALP 2.5 $CMRX — STOCK & OPTION PLAY
FIRST SIGNED OF MORE UPTREND: $2.64
NEED IT TO BREAK OVER: $2.75
key indicator for MORE uptrend $2.87
confirmation uptrend - $2.96
mini breakout - $3.01. $Chimerix(CMRX.US)$